Overview: On June 9, 2022, Johnson & Johnson Innovation – JLABS (JLABS) and the Biomedical Advanced Research and Development Authority (BARDA) will host the second BLUE KNIGHT™ Symposium. Join us for a global conversation with innovators, investors, partners and thought leaders to discover and accelerate next-gen potential solutions for future pandemics, emerging infectious diseases, and other known and unknown health threats.
Be sure to register for a full day of programming streaming virtually from JLABS @ Washington, DC, and other sites globally.
About BLUE KNIGHT™: Blue Knight is a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services. This collaboration aims to stimulate the innovation and incubation of science and technologies that may improve health security and response by supporting companies focused on public health threats and emerging infectious diseases. Find out more about BARDA and its mission at www.medicalcountermeasures.gov.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
